Steven Cohen’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.2K Buy
+36,134
New +$69.8K ﹤0.01% 3741
2026
Q2
– Sell
-41,095
Closed -$82.4K – 3959
2026
Q1
$82.4K Buy
41,095
+20,878
+103% +$39.8K ﹤0.01% 3630
2025
Q4
$22.8K Buy
+20,217
New +$30.6K ﹤0.01% 3829
2024
Q3
– Sell
-304,100
Closed -$1.83M – 1954
2024
Q2
$1.83M Buy
+304,100
New +$3.74M ﹤0.01% 1119
2024
Q1
– Sell
-913,700
Closed -$13.6M – 2142
2023
Q4
$13.6M Buy
+913,700
New +$8.67M 0.03% 579
2023
Q2
– Sell
-13,556
Closed -$61.3K – 2135
2023
Q1
$61.3K Sell
13,556
-71,444
-84% -$541K ﹤0.01% 1747
2022
Q4
$958K Sell
85,000
-297,500
-78% -$3.34M ﹤0.01% 1055
2022
Q3
$3.66M Buy
+382,500
New +$4.46M 0.01% 809

Other funds holding ALXO

Steven Cohen's ALXO Position: Q3 2026 in Review

Steven Cohen opened a new position in ALX Oncology (ALXO) in Q3 2026: 36,134 shares worth $50.2K. The stake represents ﹤0.01% of the portfolio and ranks #3741 among its holdings. This is a return to the name: Steven Cohen previously reported a position in ALXO as recently as Q1 2026.

Steven Cohen first reported a position in ALXO in Q3 2022 and has held it in 8 quarters since. The position peaked at $13.6M in Q4 2023. 112 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

  • Steven Cohen held 36,134 shares of ALX Oncology worth $50.2K as of Q3 2026.
  • ALX Oncology was a new Steven Cohen position in Q3 2026.
  • ALX Oncology made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3741 holding.
  • Steven Cohen first reported a position in ALX Oncology in Q3 2022 and has held it in 8 quarters since.
  • Steven Cohen's ALX Oncology position peaked at $13.6M in Q4 2023.
  • 112 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.